Innovent Biologics Executive and Leadership Team

Jay Schabel, the Chief Executive Officer at Innovent Biologics, directs the company's overall strategic vision and operational execution. Schabel guides the organization's commitment to advancing biopharmaceutical research and development, focusing on novel therapies for critical diseases like cancer and autoimmune disorders. Overseeing all major business functions, the Chief Executive Officer ensures alignment with the company's mission to deliver high-quality, innovative treatments to patients. This leadership role involves fostering a culture of scientific excellence and driving market penetration for the company's cutting-edge products. Jay Schabel's strategic direction is pivotal in expanding Innovent Biologics' impact within the global healthcare landscape, ensuring the company remains at the forefront of biopharmaceutical innovation and patient care.

Huang Xiaole, the Vice President of Office of Chief Executive Officer and President at Innovent Biologics, supports the strategic initiatives and operational oversight directed by the Chief Executive Officer and President. Xiaole facilitates critical communication and coordination across various departments, ensuring seamless execution of company-wide objectives. This role involves managing key projects and driving efficiency within the executive office, directly contributing to the company's focus on developing and producing innovative biopharmaceuticals. Overseeing the operational flow within the executive leadership structure, Huang Xiaole ensures that Innovent Biologics' advanced therapies for oncology and autoimmune disorders reach healthcare providers and patients effectively. The Vice President of Office of Chief Executive Officer and President plays a crucial part in maintaining the company's commitment to quality and innovation, supporting the delivery of effective treatment options.

Rachel You, the Chief Financial Officer at Innovent Biologics, manages the company's financial strategy and fiscal operations. You oversees all aspects of financial planning, budgeting, and reporting, ensuring the economic viability and sustainable growth of the organization. This leadership position is critical for allocating resources effectively towards research, development, and production of innovative biopharmaceuticals. The Chief Financial Officer guides investment decisions, manages capital structure, and ensures compliance with financial regulations, supporting Innovent Biologics' mission to provide advanced therapies. Rachel You's financial acumen is essential for driving the company's market position and securing funding for its cutting-edge products, particularly in the competitive oncology and autoimmune disorder treatment sectors. Her oversight ensures financial health, enabling the company to pursue its goals of improving patient outcomes.

Qinwei Zhou, the Chief Operating Officer at Innovent Biologics, directs the company's operational efficiency and production capabilities. Zhou oversees the manufacturing processes, supply chain management, and quality control systems essential for delivering innovative biopharmaceuticals. This role is fundamental to ensuring the consistent production of advanced therapies for diseases such as cancer and autoimmune disorders, meeting the demands of healthcare providers and patients. The Chief Operating Officer drives operational excellence, optimizing workflows to enhance productivity and reduce costs while maintaining the highest standards of quality. Qinwei Zhou's leadership ensures that Innovent Biologics can scale its operations effectively to support its growing portfolio of cutting-edge products. His focus on operational integrity is key to the company's commitment to improving patient outcomes through reliable and effective treatments.

Yuan Zhang, the President Office at Innovent Biologics, supports the strategic direction and operational management of the company's executive leadership. Zhang facilitates key administrative functions and project coordination, ensuring the smooth execution of initiatives related to biopharmaceutical research and development. This role is integral to the company's mission of providing advanced therapies for oncology and autoimmune disorders, bridging executive strategy with practical implementation. The President Office contributes to maintaining high standards of quality and innovation across the organization. Yuan Zhang's efforts are vital in supporting the President and Chief Executive Officer, ensuring that Innovent Biologics effectively delivers its cutting-edge products to healthcare providers and patients seeking improved treatment options. This position reinforces the company's commitment to advancing patient care through dedicated operational support.